Associated Papers
In silico analysis of alpha-synuclein protein variants and posttranslational modifications related to Parkinson's disease.
da Silva ANR et al.
Journal of Cellular Biochemistry, 2024
Synucleinopathies: Intrinsic and Extrinsic Factors.
Lomeli-Lepe AK et al.
Cell Biochemistry and Biophysics, 2023
Classification of domains in predicted structures of the human proteome.
Schaeffer RD et al.
Proceedings of the National Academy of Sciences of the United States of America, 2023
Structural and Functional Insights into α-Synuclein Fibril Polymorphism.
Mehra S et al.
Biomolecules, 2021
Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies.
Gámez-Valero A et al.
Genes, 2018
A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.
Moriarty GM et al.
The Journal of Biological Chemistry, 2017
Molecular Genetics of Neurodegenerative Dementias.
Hinz FI et al.
Cold Spring Harbor Perspectives in Biology, 2017
Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity.
Tenreiro S et al.
Human Molecular Genetics, 2016
The loss of inhibitory C-terminal conformations in disease associated P123H β-synuclein.
Janowska MK et al.
Protein Science : a Publication of the Protein Society, 2016
Role of genomics in translational research for Parkinson's disease.
Sekiyama K et al.
Biochemical and Biophysical Research Communications, 2014
A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain.
Fujita M et al.
Nature Communications, 2010
Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies.
Wei J et al.
The American Journal of Pathology, 2009
Familial occurrence of dementia and parkinsonism: a systematic review.
Kurz MW et al.
Dementia and Geriatric Cognitive Disorders, 2006